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1078–5884/00Improvement of the Walking Ability in Intermittent
Claudication due to Superficial Femoral Artery Occlusion
with Supervised Exercise and Pneumatic Foot and Calf
Compression: A Randomised Controlled Trial
S.K. Kakkos,1,2 G. Geroulakos1,2* and A.N. Nicolaides1,21Vascular Unit, Ealing Hospital, Southall, Middlesex, and 2Department of Vascular Surgery, Imperial College
of Science, Technology and Medicine, London, UKObjectives. To compare the effect of unsupervised exercise, supervised exercise and intermittent pneumatic foot and calf
compression (IPC) on the claudication distance, lower limb arterial haemodynamics and quality of life of patients with
intermittent claudication.
Methods. Thirty-four eligible patients with stable intermittent claudication were randomised to IPC (nZ13, 3 h/d for 6
months), supervised exercise (nZ12, three hourly sessions/week for 6 months) or unsupervised exercise (nZ9). In each
patient, initial claudication distance (ICD), absolute claudication distance (ACD), resting ankle brachial pressure index
(ABPI), and resting hyperaemic calf arterial inflow were measured before, 6 weeks, 6 months and 1 year after randomisation.
Quality of life was assessed with the short form (SF)-36, walking impairment (WIQ) and intermittent claudication
questionnaires (ICQ).
Results. Compared with unsupervised exercise, both IPC and supervised exercise, increased ICD and ACD, up to 2.83
times. IPC increased arterial inflow (p!0.05 at 6 weeks) and ABPI. Supervised exercise decreased arterial inflow and
increased ABPI (p!0.05 at 6 months). Unsupervised exercise had no effect on arterial inflow or ABPI. IPC improved
significantly the ICQ score and the speed score of the WIQ, while supervised exercise improved the WIQ claudication
severity score. At 1 year clinical effectiveness of supervised exercise and IPC was largely preserved.
Conclusions. IPC, by augmenting leg perfusion, achieved improvement in walking distance comparable with supervised
exercise. Long-term results in a larger number of patients will provide valuable information on the optimal treatment
modality of intermittent claudication.Keywords: Intermittent claudication; Supervised exercise; Intermittent pneumatic compression.Introduction
The annual incidence of intermittent claudication is
approximately 20 per 1000 in men and women older
than 65 years.1 In the USA it is estimated that up to 1.3
million elderly persons can be expected to develop
disabling claudication symptoms every 2 years during
the next 50 years.2 Therefore, the economic impact of
intermittent claudication is substantial.
Treatment options to improve walking distance inpart at the XVIII annual meeting of the European
Vascular Surgery (ESVS), September 17–19, 2004,
ustria.
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0164+ 12 $35.00/0 q 2005 Elsevier Ltd. All rights reserpatients with intermittent claudication include bypass
surgery, percutaneous transluminal angioplasty
(PTA), supervised exercise rehabilitation,2 intermittent
pneumatic compression,3 and pharmacotherapy.4
These options, however, are not applicable in all
claudicants. For example, the majority of patients are
not suitable for PTA. In one study approximately 90%
of patients who were screened were unsuitable for
treatment by PTA because of the pattern of their
occlusive disease or because of other diseases.5 PTA
usually is not recommended for superficial femoral
artery (SFA) occlusions longer than 10 cm. Exercise
rehabilitation, in the form of supervised exercise, is
effective for improving claudication symptoms, the
distance to maximal claudication pain increased by
122% in a metanalysis;2 however, the best results wereEur J Vasc Endovasc Surg 30, 164–175 (2005)
doi:10.1016/j.ejvs.2005.03.011, available online at http://www.sciencedirect.com onved.
Pneumatic Compression in Intermittent Claudication 165achieved by intense exercise three times a week for up
to 6 months. The high costs of this approach prohibit
its widespread use. Intermittent foot or foot and calf
compression is effective in increasing the claudication
distance by two and half times and, therefore, an
attractive alternative, suitable for home use.6,7
The main aim of our study was to test the
hypothesis that intermittent pneumatic compression,
used at home, would be at least as effective as
supervised leg exercise in improving claudication
distance in patients with SFA occlusion and that both
treatment modalities were much more effective com-
pared to unsupervised exercise (advice for exercise),
which in addition to anti-platelet use and risk factor
modification is currently the most popular way to treat
this condition in the UK. A secondary aim was to
determine the impact of intermittent pneumatic
compression, supervised exercise and unsupervised
exercise on the quality of life (QoL).Material and Methods
Patients with stable intermittent claudication for
longer than 6 months due to SFA occlusion R6 cm in
length on ultrasound and/or angiogram were
recruited from the vascular outpatient clinics. The
San Diego claudication questionnaire was used to
assess leg symptoms.8 Patients were excluded if
duration of symptoms was less than 6 months, they
had previous angioplasty or arterial surgery to the
symptomatic leg, myocardial infarction within the
previous 6 months, inability to manage the treadmill
examination or training and any psychiatric illness or
other reason making follow up difficult, ischaemic rest
pain, gangrene or ischaemic ulceration, were not able
to attend the supervised exercise programme or had
severe peripheral neuropathy (diabetes, etc.), which
can probably precipitate soft tissue injury when using
the compression device, ankle brachial pressure index
at enrolment greater than 0.9 or non compressible calf
arteries (diabetes, chronic renal failure, etc.) preclud-
ing ABPI measurement, iliac occlusions or stenoses
amenable to surgery or angioplasty (based on ultra-
sound scanning or angiogram), femoral artery occlu-
sion less than 6 cm as shown on duplex, suitable for
angioplasty and limited exercise capacity caused by
symptoms of angina, congestive heart failure, chronic
obstructive pulmonary disease, disease of the spinal
column, venous disease, neurological disease, mental
illness or arthritis. Treadmill testing was subsequently
performed and patients with maximum claudication
distance greater than 300 m or less than 50 m, also
were excluded. Two screening treadmill testsperformed 1 week apart that did not differ by more
than 25% in terms of absolute claudication distance
was an additional requirement; in such a case, a third
treadmill test was performed and if it was different by
more than 25% in terms of absolute claudication
distance from both screening treadmill tests, the
patient was excluded.Methodology
ABPI measurements
After the patient had rested for 15 min both brachial
pressures were measured twice with a standard
stethoscope, sphygmomanometer and a wide (12 cm)
arm blood pressure cuff and the results averaged. The
mean of the measurements of the two arms were taken
into account if their difference was less than 10 mmHg,
otherwise the maximum pressure was used. Ankle
blood pressure was measured bilaterally with a
directional continuous-wave Doppler, a narrow
(10 cm) ankle pressure cuff and a sphygmomanometer.
Posterior tibial and dorsalis pedis pressure measure-
ments were performed three times and the results
averaged. The vessel with the highest average press-
ure was considered the index vessel.
Treadmill testing
This was carried out on a constant load treadmill test
(10% gradient, 3.5 km/h), in accordance with the
German Society for Angiology (DGA, Deutsche
Gesellschaft fu¨r Angiologie) guidelines.9 Since walk-
ing distance on the treadmill can vary,10 the average of
two tests was considered. Initial and absolute claudi-
cation distance were recorded, which is the distance at
which pain first occurs (ICD, bilaterally when both
legs were affected) and the maximum distance
terminated by pain (ACD), respectively.
Calf arterial inflow
The global resting calf arterial inflow was measured
with the venous occlusion air plethysmography
technique,11 in the supine position after 15 min of
resting. This was performed by means of an air-
plethysmograph (APG-1000; ACI Medical Inc., San
Marcos, CA, USA) and a thigh-congesting cuff (17 cm
contoured thigh calf) inflated to 60 mmHg for 15-s by a
rapid cuff inflator (E10, DE Hockanson Inc., Bellevue,
WA, USA) to induce venous occlusion. Five serial
measurements were averaged. Arterial inflow follow-
ing thigh occlusion reactive hyperaemia (abrupt
release of a supra-knee thigh occlusion for 5 min at
50 mmHg above the pressure where pedal blood flow
ceased, as determined by an audible transcutaneousEur J Vasc Endovasc Surg Vol 30, August 2005
S. K. Kakkos et al.166Doppler flow probe, to minimise soft tissue com-
pression and subject discomfort) was also measured
serially for 4 min.12 The thigh-congesting cuff was
inflated to 60 mmHg for 7.5 s in each 15-s cycle. Three
serial measurements were obtained to calculate the
mean. Reactive hyperaemic calf arterial inflow was
normalized for resting flow (reactive hyperaemic flow
ratio), while the hyperaemic index (ratio of the excess
area under the hyperaemic curve/peak flow) was also
calculated.13,14
Quality of life assessment
QoL was assessed with the short form-36 (SF-36)
health survey questionnaire, which is a self-adminis-
tered generic QoL questionnaire developed for the
Medical Outcomes Study.15 Although it has been
shown to be sensitive in defining changes following
various treatment modalities in patients with claudi-
cation, including surgery and PTA,16 it can miss small
but important changes of QOL.17 For this reason, two
disease specific instruments were used, the walking
impairment questionnaire (WIQ),18 and the intermit-
tent claudication questionnaire (ICQ).19 WIQ is an
interviewer administered, disease-specific instrument,
while ICQ is a disease-specific QoL questionnaire. The
former provides different scores for claudication pain
severity for each leg, scores for walking impairment
due to other causes (exertional symptoms limiting
walking, including chest pain, shortness of breath,
joint pain, etc), and three scores for walking distance,
speed and stairs climbing.
Randomisation
Patients were randomised to one of the following three
groups: unsupervised exercise (control group), super-
vised exercise or intermittent pneumatic compression.
A blind, block ‘telephone’ randomisation procedure
by means of a computer was performed. Patients of
the three groups were stratified by age (younger or
older than 67 years of age) and absolute claudication
distance (less or more than 150 m). Randomisation
was performed by the Clinical Trials and Evaluation
Unit at the Royal Brompton Hospital in London. All
patients gave their written informed consent, the
study protocol being approved by the Hospital Ethics
Committee.
Treatment
Current smokers were advised to stop smoking,
antiplatelet therapy, preferably 75 mg aspirin once
daily, was commenced if the patient was not already
on it and lipid-lowering agents (statins) were pre-
scribed and titrated to reduce LDL serum levels below
2.5–3 mmol/L, if necessary.Eur J Vasc Endovasc Surg Vol 30, August 2005Patients allocated to unsupervised exercise (control
group) were advised to exercise daily by walking as
much as possible to near maximal pain, for a period of
at least 45 min.
Patients allocated to supervised exercise were
advised to exercise daily by walking as much as
possible to near maximal pain and in addition attend a
supervised exercise programme for 6 months.
Patients allocated to intermittent pneumatic com-
pression were advised to exercise daily by walking as
much as possible to near maximal pain and in addition
have intermittent pneumatic compression of the
symptomatic foot and calf for 6 months.
Exercise programme
Patients attended the physiotherapy department for
exercise therapy three times per week for the first 6
months. Compliance was assessed with logbooks.
Supervision was provided on an individual or
group basis and each session lasted for about 60 min.
A session consisted of 5 min warm up activities,
50 min of intermittent exercise and ended with 5 min
of cool-down activities. Walking treadmill exercise
was started at a low treadmill workload of 2 mph, 0%
grade. Patients walked until claudication pain become
moderately severe, at which time they step off the
treadmill and rest until claudication pain subsides.
After the patient had walked 8–10 min at the initial
workload, either the grade was increased by 1–2%, or
the speed was increased by 0.5 mph as tolerated.
Further progressive increases in the speed and grade
were performed as tolerated.20
Intermittent foot and calf pneumatic compression
Intermittent pneumatic compression of the foot and
calf was performed with the patient in a sitting
position. The ArtAssistw device (model AA-1000, San
Marcos, CA, USA) was used, which has a frequency of
three impulses per min, with a delay of 1 s for calf
compression and an inflation pressure of 120 mmHg.
Patients were advised to use the pneumatic com-
pression daily in a sitting position usually while
watching TV at times of their convenience for a total
duration of about 3 h. Intermittent pneumatic com-
pression was performed bilaterally in cases of bilateral
claudication. Compliance was assessed with the use of
built-in time meters.
Follow-up
Patients were re-assessed at 6 weeks and 6 months
after randomisation, for the development of adverse
events and assessment of claudication using the same
methodology as on baseline. Patients who stopped
using the IPC device or the exercise programme,
Pneumatic Compression in Intermittent Claudication 167continued to be followed-up, unless they withdrew
their consent. Finally, patients were re-assessed at
12 months after randomisation to determine the
stability of clinical improvement for the 6-month
period after the end of ‘active’ treatment. During the
second part of the study, advice on exercise was
the same for all patients and similar to that given to the
unsupervised exercise group.Fig. 1. Flow diagram showing the progress through theStatistical analysis
Power calculations had demonstrated that 15 patients
would be needed in each group to demonstrate a 100%
increase in claudication distance from 100 to 200 m
(comparable to that quoted by Gardner2 for super-
vised exercise and Delis for IPC3), at significance level
of 0.01 (aZ0.01) and power of 80% (1KbZ0.8). All
results are shown as median and interquartile range;phases of the trial, up to the end of active treatment.
Eur J Vasc Endovasc Surg Vol 30, August 2005
S. K. Kakkos et al.168because data distribution was skewed, distribution-
free tests were used for statistical analysis. Demo-
graphic data of the three groups at baseline were
compared with the Kruskal–Wallis test (numerical
data) or chi-square (categorical data). Analysis was by
intention to treat. Inter-groups analysis was assessed
with the Mann–Whitney test and intra-group analysis
with the Wilcoxon signed-rank test and exact tests
were used (2-sided or 1-sided, where appropriate).
Categorical data were analysed with chi-square or
Fisher’s exact test, where appropriate. Multiple intra-
group comparisons over time were assessed with the
Friedman test. SPSS for Windows, version 11.5 (SPSS
Inc., Chicago, IL, USA), was the statistical package
used for statistical analysis. p values of 0.05 or less
were considered statistically significant.Results
One hundred fifty-one patients were screened and 34
of them (23%) were eligible for randomisation (Fig. 1).
Nine patients were randomised to unsupervised
exercise, 12 to supervised exercise and 13 to IPC.
Patient demographics and risk factors are shown in
Table 1. The three groups werematched for risk factors
and also for ACD (Table 2). In 19 cases the left leg was
the index leg and in 15 cases this was the right one.
Two patients in the IPC group withdrew their
consent before their 6 weekly and 6 monthly appoint-
ments, respectively, the former patient because of
generalised weakness. An additional patient devel-
oped hip osteoarthritis and could not be tested on the
treadmill at 6 months and 1 year. One more patient
who was an inpatient with chest infection could not
have his walking distance assessed at 6 months. One
patient in the unsupervised exercise developed restTable 1. Patient demographics and risk factors at baseline
Risk factor Unsupervised
exercise (nZ9)
Supervised
exercise (nZ1
Age (years) 66 (10.5) 69 (11.8)
Male gender 8 (89%) 11 (92%)
Coronary heart disease 1 (11%) 2 (17%)
CABG 1 (11%) 0 (0%)
Smoking
Currently 3 (33%) 2 (17%)
Previously 6 (67%) 8 (67%)
Packs!years 40 (43.7) 41.3 (23)
Hypertension 2 (22%) 4 (33%)
Hypercholesterolaemia 5 (56%) 5 (42%)
Diabetes mellitus 1 (11%) 3 (25%)
Family history of atherosclerosis 3 (33%) 6 (50%)
BMI (Kgr/m2) 24.7 (10.9) 24.9 (5.3)
Results are shown as number of cases (percentage) or median (IQR). K
Eur J Vasc Endovasc Surg Vol 30, August 2005pain due to SFA occlusion of the contra-lateral leg,
before his 6-month appointment and subsequently
had a femoropopliteal bypass. Only one patient of this
group withdrew at 1 year because he moved out of the
area. Two patients randomised to supervised exercise
withdrew their consent at week 6. Between week 6 and
month 6, four additional patients stopped physiother-
apy because of fatigue, GI bleeding, minor domestic
leg injuries and bladder cancer, respectively. The latter
patient, who developed acute leg ischaemia following
his cancer operation and subsequently died and the
patient with the leg injury did not have their walking
distance assessed at 6 months. At 1 year two additional
patients allocated to supervised exercise withdrew
their consent.
Compared to baseline, IPC and supervised exercise
increased ICD and ACD (up to 2.83 times, p!0.05,
Table 2 and Fig. 2), IPC being more effective. ICD and
ACD did not practically change in patients allocated to
unsupervised exercise. Patients maintained this
improvement at 1 year, although ACD in the IPC
was reduced (pZ0.063 compared to 6 months).
Compared with unsupervised exercise (inter-group
analysis), both IPC and supervised exercise increased
significantly ACD at 6 months (p!0.05), which was
maintained at 1 year. There was no statistical signifi-
cant difference in the walking distance (ICD and ACD)
achieved by IPC and supervised exercise at 6 weeks, 6
months and 1 year (all p values O0.40).
IPC increased resting arterial inflow by 28% (p!0.05
at 6 weeks); this was decreased by supervised exercise,
while unsupervised exercise had no effect (Table 2). IPC
decreased the reactive hyperaemic flow ratio at 15 and
30 s (at 6 weeks and 6 months, p!0.05), as shown in
Fig. 3, while exercise had no effect. The hyperaemic
index was increased by exercise and decreased by IPC,
but the difference was not significant.2)
IPC (nZ13) All patients
(nZ34)
p value
66 (7) 66.5 (8) 0.82
8 (62%) 27 (79%) 0.13
3 (23%) 6 (18%) 0.77
3 (23%) 4 (12%) 0.20
6 (46%) 11 (32%) 0.23
7 (54%) 21 (62%) 0.23
40 (40) 40 (34.2) 0.91
9 (69%) 15 (44%) 0.60
5 (54%) 17 (50%) 0.77
3 (13%) 7 (21%) 0.71
7 (54%) 16 (47%) 0.62
24.8 (5.7) 24.7 (5.7) 0.95
ruskal–Wallis test or chi-square was used where appropriate.
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Pneumatic Compression in Intermittent Claudication 169Supervised exercise increased ABPI by 0.11 (p!
0.01) at 6 months, but this decreased after physiother-
apy was stopped and was not significant at 1 year.
Smaller increase seen in the IPC and unsupervised
exercise groups did not reach statistical significance.
ABPI of the contralateral leg did not show any
consistent changes (Table 2).
Two patients, smokers at the beginning of the study,
quit smoking at 6 months, 5 patients reduced the
number of cigarettes by 59% on average, while no
change was reported by 4 patients. At 1 year two
additional patients had quit and another one reduced
the number of cigarettes by 33%. Although smoking
reduction at 6 months (by at least 40%) was associated
with an increase in walking distance (gain 425 m),
compared to those who did not reduced by 40%
(gain 30 m), the difference was not significant (pZ
0.46). Two patients in the supervised exercise group
(pZ0.49), four patients in the IPC group reduced
smoking (pZ0.12) but none in the unsupervised
exercise group. Exclusion of those patients who
reduced smoking did not alter significantly ACD,
which increased by 4, 52 and 250%, in patients
allocated to unsupervised exercise, supervised exer-
cise and IPC, respectively. Patients with less than the
median ACD (145 m) increased their ACD from 110 to
120 m, compared to a similar increase (from 210 to
220 m) in the remainder.
Patients younger than the median age (67 years)
increased their ACD from 135 to 140 m, compared to a
bigger increase (from 160 to 220 m) in the remainder.
Compliance in the IPC group ranged from 7 to 70%
(median 35%) of the expected use (548 h). Attendance
rates of the supervised exercise classes ranged from
12.8 to 100% (median 60.3%) of the expected attend-
ance (72 days).
General health, as assessed by the SF-36 was not
severely affected by this claudication programme
(Tables 3 and 4). Score for the general health domain
of the SF-36 was significantly improved at 1 year in
patients who used IPC. Forty percent of these patients
reported that their general health was better compared
to 1 year ago versus none of those allocated to
unsupervised exercise (4/6 vs 0/6, pZ0.06). WIQ
scores for walking distance, walking speed and stair
climbing were reduced in the unsupervised exercise
group, remained stable in the supervised exercise
group and increased in the IPC group (Fig. 4). Walking
speed score in the latter group was increased
significantly at 6 months. Supervised exercise
improved the claudication (pain) severity score of
the WIQ questionnaire (Fig. 5). The most remarkable
change seen among the ‘walking impairment due to
other causes’ questions of the relevant section of theEur J Vasc Endovasc Surg Vol 30, August 2005
Fig. 2. This figure demonstrates a significant improvement in
walking distance, in patients allocated to supervised exercise
or intermittent pneumatic leg compression, compared to
baseline (at 6 weeks, 6 months and 1 year) and unsupervised
exercise (at 6 months and 1 year).
S. K. Kakkos et al.170WIC, was in the question exploring joint symptoms
(‘pain, stiffness or aching in your joints: ankles, knees
or hips’), observed in the supervised exercise group at
6 months (50% drop of the medium score, from 100 to
50%). Supervised exercise and IPC reduced
(improved) the ICQ score, but this was significant
only in the IPC group (Fig. 6).Discussion
Suction leg devices or devices applying positive
pressure in combination with suction have been used
for nearly a century to treat patients with Burger’s
disease or symptomatic peripheral vascularFig. 3. Reactive hyperaemic flow changes (normalised for
resting flow) at 6 weeks and 6 months of IPC. The difference
was significant at 15 and 30 s. At 1 year flow returned to
baseline.
Eur J Vasc Endovasc Surg Vol 30, August 2005disease.21–23 These devices produced hyperaemia
and increased skin temperature. Subsequent improve-
ment of our knowledge of the physiology of leg
compression has resulted in abandonment of the use
of leg suction. More recently, our group determined
the optimum intermittent pneumatic compression
stimulus for lower-limb venous emptying using direct
pressure measurements; foot and calf compression at
120–140 mmHg, with a frequency of 3–4 impulses/
minute and one-second delay, provides the optimum
stimulus.24 Intermittent pneumatic leg compression
using these setting has been subsequently used in
claudicants,7 and in critical limb ischaemia, when
surgical reconstruction is not feasible.25,26
IPC in this study improved remarkably walking
distance, mainly ACD, by 183%. Similar results with
the use of foot and calf compression have been
previously reported by our group (212% increase),24
while the use of a foot pump seems to be somewhat
inferior (106% improvement).6 Walking distance
improvement with IPC was comparable or even better
than supervised exercise; perhaps the relatively high
dropout rate in this supervised exercise group
explains the inferior results, compared to the mean
of 122% reported in a metanalysis.2 No practical
improvement (4% increase in walking distance) was
observed in patients allocated to unsupervised exer-
cise, which seems contradictory to previous studies,
which reported a small (18%) increase in walking
distance;4 however, ICD was somewhat improved.
Most of the patients had already given advice to stop
smoking and exercise by their family doctors before
entering the study and the fact that they presented
with SFA occlusion, with no previous episodes of leg
ischaemia (indicating adequate collateral circulation),
could explain the stability of their clinical condition.
ABPI increased in both supervised exercise and
pneumatic compression. The 11% ABPI increase in the
latter group did not achieve statistical significance,
probably because the study did not have the appro-
priate power, however, in a similar but larger study it
did reach statistical significance7 ABPI increase in
supervised exercise is not in agreement with previous
studies,27,28 which found no such a finding; perhaps in
this selected group of patients with SFA occlusion,
exercise results in remodelling of thigh collaterals and
therefore ABPI increase. The effect of calf and thigh
IPC,29 on this group of patients can be only speculated.
Notably, ABPI of the contralateral leg was rather
reduced, indicating a differential effect of exercise
in this group. This was remarkably reduced in
unsupervised exercise and practically unchanged in
supervised exercise.
An increase in resting arterial inflow was observed
Table 3. Physical health domain changes of the SF-36 health questionnaire at 6 weeks, 6 months and 1 year after entry into the study
Unsupervised
exercise
p Supervised
exercise
p IPC p
Physical functioning
Baseline 50 (35–65) 65 (56–70) 70 (50–80)
6 weeks 50 (43–68) 0.5 55 (50–55) 0.133 68 (48–84) 0.875
6 months 60 (46–69) 0.343 65 (50–73) 0.180 73 (39–85) 0.887
12 months 45 (35–60) 0.531 50 (35–65) 0.063 75 (58–90) 0.242
Role-physical
Baseline 100 (50–100) 50 (50–94) 100 (50–113)
6 weeks 100 (75–100) 0.672 50 (50–100) 1.000 50 (50–75) 0.016
6 months 75 (56–94) 1.000 50 (38–50) 0.343 50 (50–81) 0.188
12 months 50 (25–100) 0.250 0 (0–100) 0.250 0 (0–81) 0.004
Bodily pain
Baseline 60 (32–77) 60 (51–78) 60 (46–75)
6 weeks 54 (42–92) 0.375 64 (60–84) 0.039 70 (61–80) 0.875
6 months 62 (43–70) 0.813 70 (48–90) 1.000 70 (58–80) 0.297
12 months 51 (31–74) 0.672 62 (41–84) 1.000 72 (61–88) 0.164
General health
Baseline 35 (28–59) 35 (26–45) 35 (25–48)
6 weeks 40 (23–55) 0.531 40 (35–55) 0.055 35 (21–39) 0.266
6 months 40 (35–49) 0.625 35 (30–43) 0.797 33 (24–41) 0.203
12 months 40 (35–45) 0.828 50 (42–72) 0.094 61 (45–70) 0.037
Physical composite score
Baseline 52 (45–62) 49 (41–61) 62 (50–66)
6 weeks 54 (46–62) 0.383 55 (52–58) 0.331 55 (52–58) 0.458
6 months 53 (50–55) 0.523 52 (35–61) 0.641 56 (51–58) 0.645
12 months 47 (43–57) 0.469 48 (40–54) 0.688 56 (48–64) 0.695
Wilcoxon test was used for intra-group analysis.
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similar trial, however, resting arterial flow (assessed
with ultrasound at the level of the popliteal artery) did
not change.7 These observations after weeks or months
of leg compression should be distinguished fromTable 4. Mental health domain changes of the SF-36 health question
Unsupervised
exercise
p Supervise
exercise
Vitality
Baseline 60 (65–43) 70 (60–70)
6 weeks 60 (50–68) 0.281 65 (50–70)
6 months 65 (46–70) 0.343 60 (50–75)
12 months 50 (45–60) 0.500 50 (45–60)
Social functioning
Baseline 78 (67–78) 78 (69–89)
6 weeks 78 (44–89) 0.656 78 (67–89)
6 months 72 (58–78) 0.312 78 (72–83)
12 months 89 (22–100) 0.938 89 (78–100
Role emotional
Baseline 33 (0–33) 0 (0–25)
6 weeks 33 (17–83) 0.125 33 (0–33)
6 months 33 (33–33) 0.250 0 (0–33)
12 months 67 (0–100) 0.125 0 (0–33)
Mental health
Baseline 52 (38–66) 44 (32–52)
6 weeks 52 (48–58) 0.914 48 (40–52)
6 months 44 (37–64) 0.797 56 (40–60)
12 months 88 (64–100) 0.031 76 (60–80)
Mental composite score
Baseline 51 (38–62) 54 (47–62)
6 weeks 58 (49–65) 0.516 57 (46–63)
6 months 58 (47–66) 0.563 51 (41–63)
12 months 63 (49–79) 0.078 53 (49–62)findings of acute studies, which measured the clear-
ance time of 133Xe,31 or arterial flow using duplex
ultrasonography;32,33 these are the result of reactive
hyperaemia or a result of decreasing venous pressure
and widening the so-called arteriovenous pressurenaire at 6 weeks, 6 months and 1 year after entry into the study
d p IPC p
65 (50–70)
0.344 55 (48–70) 1.000
0.382 70 (65–71) 0.008
0.078 68 (50–76) 0.313
78 (67–89)
0.531 78 (58–78) 0.469
0.750 78 (72–89) 1.000
) 0.343 94 (75–100) 0.068
33 (0–83)
0.156 33 (0–33) 0.180
0.750 0 (0–8) 0.063
1.000 0 (0–42) 0.156
52 (36–64)
0.602 44 (33–52) 0.078
0.125 42 (31–57) 0.297
0.016 84 (71–89) 0.008
57 (47–68)
0.418 58 (43–65) 0.606
0.492 61 (58–68) 0.652
0.813 63 (48–71) 0.084
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Fig. 4.WIQ scores for walking distance (WD), walking speed (WS) and stair climbing (SC) were reduced in the unsupervised
exercise group, remained stable in the supervised exercise group and increased in the IPC group. Higher scores indicate a less
severely affected patient. IPC improved walking speed score (pZ0.007, exact Friedman test), which was significant at 6
months (asterisk).
S. K. Kakkos et al.172gradient. Because flow enhancement is significantly
increased in the sitting position by 187%,31 IPC devices
are traditionally used in this position. Interestingly
patients allocated to supervised exercise in our study
demonstrated a consistent decrease in arterial inflow,
which is contradictory to what previously described.34
Unsupervised exercise was associated with a smaller
decrease in resting arterial inflow, confirming previous
findings.35 Distinctive changes in reactive hyperaemic
indices were observed; exercise increased the hyper-
aemic index and IPC decreased it. The latter obser-
vation is an indication of improved leg perfusion.
Using an isotopic clearance method, normal legs have
been reported to have a low post-exercise hyperaemic
index,14 results compatible with the decrease we
found in patients who used IPC. Although these
results were not significant, the early changes (15 and
30 s) of the reactive hyperaemic curve were significant
indeed.
Quality of life improvement is obviously the
desired outcome of any treatment. Generic question-
naires have been criticised of missing small but
important changes of QOL, therefore, disease specific
questionnaires have been introduced. We found that
both IPC and supervised exercise, but not unsuper-
vised exercise, improve both the ICQ and WIQ scores.
This has enormous implications for future patient
management. IPC increased scores for walking dis-
tance and speed at 6 months by 115 and 414%,
respectively. The corresponding figures reported in
one of the cilostazol trials were 61 and 22%, respect-
ively.4 ICQ score at 6 months in the IPC andEur J Vasc Endovasc Surg Vol 30, August 2005supervised exercise groups was reduced by 33 and
17%, respectively. By contrast, the inventors of this
score reported a 43% reduction after supervised
exercise and a 41% reduction after angioplasty.19,36
Different patient selection criteria are likely to be
responsible for any differences. No consistent changes
in the SF-36 domain scores were observed, including
physical functioning, previously reported to be
improved.18
Compliance was relatively poor in both active
groups. This is in agreement with previous studies
quoting similar use of the IPC device,25 and super-
vised exercise dropout rates.37 This could explain the
relatively small improvement at 6 months in the
physiotherapy group, taken into account that patient
follow-up continued even after they discontinued the
study. No patient developed acute ischaemia in the
IPC group, which indicates that it is a safe method.
Long-term studies to investigate if it alters the natural
history of intermittent claudication, as found in
patients with leg ulcers, are necessary.38
Cost-effectiveness of treatment is obviously a
matter of concern. From the outset of the study a
conservative estimation of the cost of a 6 month course
of supervised exercise per patient at Ealing Hospital
was £1000. The rental cost of the IPC for the same
period of time was £1263. Additional costs like
transportation were not included. The better results
at 6 months seen in the IPC group favours this
modality with cost per metre of walking distance
gained estimated to be about £5 (1263/265) compared
to £13 (1000/75) in patients having physiotherapy.
Fig. 5. This figure showsWIQ scores for claudication severity
of the index leg (A) and the contralateral leg (B). A 100%
score means no claudication pain; a 0% score means patient
limited by severe pain. Supervised exercise and intermittent
pneumatic leg compression improved the score, although
the results were significant only in the supervised exercise
group (asterisks). A variable effect was seen in the
contralateral leg.
Fig. 6. Changes of the intermittent claudication question-
naire score are shown in this figure. The improvement at the
end of active treatment was significant only in the IPC group
(pZ0.037, Friedman test, asterisks). At 1 year score did not
practically change.
Pneumatic Compression in Intermittent Claudication 173Pharmacotherapy (cilostazol) is relatively cheaper,
with cost per metre of walking distance gained
estimated to be £1.6 (£220/129m) based on the 2004
UK formulary price and the results reported by
Beebe,3 but is less effective than alternative methods.
Additionally its effects are not permanent.39 We
believe that our results are applicable to most
claudicants. About half of the excluded patients
could not manage treadmill testing (mostly shortness
of breath) or their walking distance wasO300 m. Thefact that patients are typically excluded from claudica-
tion trials (in an effort to reduce variability and
therefore increase the power of these studies) does
not imply decreased efficacy of the treatment mod-
alities.4,6,39
IPC, by augmenting leg perfusion, achieved
improvement in walking distance comparable to that
achieved with supervised exercise. No improvement
or perfusion changes were seen in patients random-
ised to unsupervised exercise. Therefore, IPC is an
alternative and effective treatment option in the
management of patients with intermittent claudica-
tion. As a result of its non-invasive nature, further
research on IPC will most likely establish this as an
attractive alternative in the management of patients
with peripheral vascular disease and long-term results
in a larger number of patients will provide valuable
information on the optimal treatment modality of
intermittent claudication. It is anticipated that the
long-term need for surgical or percutaneous interven-
tion should be reduced in those patients. We are
currently completing the 1-year of follow-up of the
patients to see if they maintain their benefit 6 months
after the discontinuation of active treatment.Acknowledgements
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